Hematology Diagnostics Market Report 2024: Increasing Demand for Point-of-Care Hematology Testing and Integration of Flow Cytometry in Hematology Analyzers - A $5.12 Billion Market by 2029
September 16, 2024 10:19 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Hematology Diagnostics...
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
September 05, 2024 11:22 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price...
Global Sickle Cell Anemia Testing & Screening Market Analysis and Forecast 2024-2030 - Rising Focus on Development of Non-Invasive, Hand-Held, and Digital Technologies
June 14, 2024 05:23 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Global Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC),...
Comprehensive Analysis of Hematology Collaboration and Licensing Deals (2016-2024) Unveiled
May 02, 2024 05:25 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.A thorough report on hematology...
Global Iron Deficiency Anemia Therapy Market Poised for Growth, Forecasted to Reach $4.6 Billion by 2030
February 01, 2024 10:05 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Global Iron Deficiency Anemia Therapy Market Analysis 2024-2034 Featuring Profiles of Leading Players Including AbbVie, Bayer, CSL Vifor, Sanofi, and Teoxane
January 24, 2024 14:20 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Iron Deficiency Anemia Therapy Market Analysis & Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting
December 09, 2023 17:02 ET
|
FibroGen, Inc.
please call Meichiel Keenan@650-219-6482 with any questions.
FibroGen/Astellas’ EVRENZO (roxadustat) Making In-Roads in European Market as In-Class Challenger, Akebia/Medice’s VAFSEO (vadadustat), Prepares for Launch in Early 2024.
December 08, 2023 09:10 ET
|
Spherix Global Insights
Exton, Pennsylvania, Dec. 08, 2023 (GLOBE NEWSWIRE) -- EVRENZO made history as the initial hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) to receive EU approval in August 2021,...
Global Hematology Collaboration and Licensing Agreements Analysis Report 2023: In-depth Understanding of Hematology Trends and Structure of Deals by Leading Biopharma Companies
November 16, 2023 07:18 ET
|
Research and Markets
Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Hematology Collaboration and...
Global Chemotherapy-Induced Anemia Market Forecast to 2027: Projections for RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating Agents (ESAs), and Iron Supplementation Treatments
November 01, 2023 08:33 ET
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Anemia Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global chemotherapy-induced...